^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

MAPK1 R135K

i
Other names: MAPK1, ERK, ERK2, MAPK2, p41mapk, PRKM1, PRKM2, Mitogen-activated protein kinase 1
Entrez ID:
Related biomarkers:
5years
Erlotinib sensitivity of MAPK1p.D321N mutation in head and neck squamous cell carcinoma. (PubMed, NPJ Genom Med)
Residues D321, R135, and E322 are in 3D proximity. MAPK1p.D321N drives marked in vivo erlotinib sensitivity, while p.R135K's effect is moderate.
Journal
|
MAPK1 (Mitogen-activated protein kinase 1)
|
MAPK1 R135K
|
erlotinib